Mp compounds

Intervention

1 paper5 findings

  • 1 lab in 1 country
  • Funders: Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas and 4 more
  • Model organisms1

Outcomes

5

Locomotor activity

upin flies1

1 study
  1. Mp compounds improve locomotor activity in flies.

    “treatment with MP compounds significantly extended the lifespan and improved the locomotor activity of a Drosophila model of the DM1 disease”

    Model organismsmyotonic dystrophy type 1 model

    A Novel Class of FKBP12 Ligands Rescues Premature Aging Phenotypes Associated with Myotonic Dystrophy Type 1

    Cells22 Nov 2024

Lifespan

upin flies1

1 study
  1. Mp compounds extend lifespan in flies.

    “treatment with MP compounds significantly extended the lifespan and improved the locomotor activity of a Drosophila model of the DM1 disease”

    Model organismsmyotonic dystrophy type 1 model

    A Novel Class of FKBP12 Ligands Rescues Premature Aging Phenotypes Associated with Myotonic Dystrophy Type 1

    Cells22 Nov 2024

Alternative splicing defects

downin human cells1

1 study
  1. Mp compounds decrease alternative splicing defects in human cells.

    “This analysis also revealed the rescue of alternative splicing events in DM1 fibroblasts treated with MP compounds.”

    Cellsmyotonic dystrophy type 1primary fibroblast

    A Novel Class of FKBP12 Ligands Rescues Premature Aging Phenotypes Associated with Myotonic Dystrophy Type 1

    Cells22 Nov 2024

Mitochondrial activity

upin human cells1

1 study
  1. Mp compounds improve mitochondrial activity in human cells.

    “reversed oxidative stress and impaired cell viability and proliferation, mitochondrial activity, and metabolic defects in DM1-derived primary fibroblasts.”

    Cellsderived from myotonic dystrophy type 1 patientsprimary fibroblast

    A Novel Class of FKBP12 Ligands Rescues Premature Aging Phenotypes Associated with Myotonic Dystrophy Type 1

    Cells22 Nov 2024

Oxidative stress and ROS signalling

downin human cells1

1 study
  1. Mp compounds decrease oxidative stress and ROS signalling in human cells.

    “The treatment with different MP compounds reversed oxidative stress”

    Cellsderived from myotonic dystrophy type 1 patientsprimary fibroblast

    A Novel Class of FKBP12 Ligands Rescues Premature Aging Phenotypes Associated with Myotonic Dystrophy Type 1

    Cells22 Nov 2024

More on Oxidative stress and ROS signalling

Latest